GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab has ...
Feb 25 (Reuters) - Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung ...
PHILADELPHIA, Jan. 17, 2025 /PRNewswire/ -- Legal-Bay LLC, a leading pre settlement funding company, reports that November's $2.2 billion ruling against GlaxoSmithKline has still not been distributed ...
Shares of GSK and Sanofi are under pressure due to increasing concerns regarding legal cases related to a potential cancer side effect from the over-the-counter heartburn medicine Zantac, according to ...
Dechert to Defend GSK in Securities Class Action Over Alleged Link Between Zantac and Carcinogenic Compound This action was surfaced by Law.com Radar, which delivers real-time alerting on new ...
The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, ...
Judge Vivian Medinilla found plaintiffs’ experts’ opinions admissible, paving way for over 72,000 cancer victims to have their day in Delaware Superior Court This moves us one step closer to justice ...
British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback